Different clinical and laboratory evolutions in ataxia-telangiectasia syndrome: report of four cases.
We report four patients with ataxia-telangiectasia syndrome that presented varied neurologic evolution. Three patients initially presented neurologic alterations of slow progression, evolving to late immunocompromised conditions. The fourth patient presented, from symptom onset, immune and neurologic debilitation, that were both severe and of fast progression. The chronological sequence of the most commonly observed immunocompromised conditions were in our patients, in ascending order, IgA deficiency, IgG2 deficiency and the neutrophil phagocytosis stage and common variable immunodeficiency. The first two reports are of sisters in whom the diagnosis was done between the ages of three and six years, having ocular apraxia, cerebellar ataxia and telangiectasia. Slow progression of neurologic debilitation was observed, without presentation of intermittent infections. The patients began presenting accentuated immunocompromised conditions at the ages of 14 and 17 years, dying at the ages of 16 and 20 years, respectively, due to severe infections that were resistant to treatment. The diagnosis of the third case was established when the patient was two years old, presenting ataxia and telangiectasia. Syndrome progression was slow, presenting at the age of eight years more accentuated neurologic disorders and IgA deficiency. The fourth case presented significant neurologic compromise at the age of five, simultaneous to IgA and IgG2 deficiency, and repeating pneumonias and sinusitis. At this time, intravenous gammaglobulin reposition was done. The neurologic and immune disorders progressed rapidly, and at the age of eight presented the inability to walk. At this time inversion of the CD4/CD8 ration was verified through laboratory tests.
Forte
W C Neves
WC
Immunology Section, Santa Casa Medical School and Hospital, São Paulo, Brazil. wilmanevesforte@yahoo.com.br
Menezes
M C Santos de
MC
Dionigi
P C Loureiro
PC
Bastos
C L A Fanuchi E
CL
D000293:Adolescent; D017668:Age of Onset; D001260:Ataxia Telangiectasia / Q000150:complications / Q000175:diagnosis / Q000235:genetics / Q000276:immunology*; D016516:CD4-CD8 Ratio; D002648:Child; D002675:Child, Preschool; D003241:Consanguinity; D018450:Disease Progression; D004198:Disease Susceptibility; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D017098:IgA Deficiency / Q000209:etiology; D016867:Immunocompromised Host; D007223:Infant; D012141:Respiratory Tract Infections / Q000209:etiology; D014820:Vitiligo / Q000209:etiology; D000509:alpha-Fetoproteins / Q000032:analysis
D000509:alpha-Fetoproteins